This site uses cookies to improve your experience. To help us insure we adhere to various privacy regulations, please select your country/region of residence. If you do not select a country, we will assume you are from the United States. Select your Cookie Settings or view our Privacy Policy and Terms of Use.
Cookie Settings
Cookies and similar technologies are used on this website for proper function of the website, for tracking performance analytics and for marketing purposes. We and some of our third-party providers may use cookie data for various purposes. Please review the cookie settings below and choose your preference.
Used for the proper function of the website
Used for monitoring website traffic and interactions
Cookie Settings
Cookies and similar technologies are used on this website for proper function of the website, for tracking performance analytics and for marketing purposes. We and some of our third-party providers may use cookie data for various purposes. Please review the cookie settings below and choose your preference.
Strictly Necessary: Used for the proper function of the website
Performance/Analytics: Used for monitoring website traffic and interactions
Information on research steps from NIDA and DEA, House progress on SAFE Banking and other key bills, Developments in Alabama and Mississippi a call to action for veterans and a profile of ASA's 2021 Researcher of the Year, Philippe Lucas.
In a landmark decision, the Drug Enforcement Administration (DEA) recently announced the reclassification of cannabis from Schedule 1 to Schedule 3, marking a significant shift in the regulatory landscape surrounding this controversial plant.
Most New Yorkers can now safely indulge in cannabis without fear of being fired, Bank of America is under fire for closing the account of an authorized cannabis research institute, and proposed legislation could help Washington, D.C. Bank of America Closes Account of DEA-Approved Cannabis Researcher.
The big news this week is that, for the first time ever, a cannabis bill, the SAFER Banking Act, got a markup in the Senate. SAFER BANKING Although the SAFE Banking Act has passed multiple times in the House of Representatives, it’s never gotten out of committee in the Senate. Spoiler alert: the two don’t mix.
Bank of America (BoA) is reportedly terminating its banking relationship with Scottsdale Research Institute (SRI), a DEA-registered facility that carries out important marijuana research. So, given the history and credibility of the Institute, why did BoA terminate the 10-year banking relationship with SRI?
Sacramento New & Review have detailed the DEA, FBI and IRS investigations and written a piece well worth reading if you want to understand how difficult it is going to be to dig out the entrenched black sector of cannabis in California. It’s incredibly unique,” DEA Special Agent in Charge Chris Nielson said of Chinese cash flows. “We
Assembly Bill 1525 allows cannabis banking under California state law. In other news, a federal court ruled that the state must turn over information concerning three marijuana businesses to the DEA. The DEA said it was necessary for an investigation into the illegal import and transport of marijuana oil from Mexico.
Congress should either legalize cannabis or stop deputizing banks as drug enforcement investigators. Although 18 states have fully legalized, cannabis is still a sticky issue for banks and other financial institutions because it remains illegal at the federal level. The State of Banking. That can prove costly.
Another potential headache for farmers is that analytical laboratories must be registered with the DEA in order to perform compliance testing. No existing cannabis labs are registered with the DEA because they handle a schedule 1 substance, which violates federal law. and seize all the testing samples. THC threshold.
The Department of Agriculture delayed a requirement that the DEA conduct all THC testing on hemp crops. He pleaded guilt y to ingesting marijuana and cocaine. FEDERAL NEWS. So what’s happening on the federal level? The requirement will take effect on October 21, 2021 or upon publication of a final rule, whichever comes first.
In other federal news, the DEA has, yet again, not approved new suppliers of marijuana for research. Meanwhile, the state of Arizona is experimenting with a new procedure to get around the lack of banking services for marijuana companies. There will have to be a bit more awaiting, it seems.
In February, we saw the first ever Congressional hearing on cannabis banking. On the federal level, however, the SAFE Banking Act was approved by the House Financial Services Committee (45-15). On to July, when the Senate Banking Committee had a hearing on cannabanking. The Senate failed to take action on the banking bill.
DEA case, Bob Hoban’s advising of more than 30 countries on cannabis policy and crafting of CBD legal strategies, and the expansion of global offices in more than 10 countries. With the anticipated passage of the SAFE Banking Act followed by the potential federal legalization of cannabis, the industry is moving at lightning speed.
Lack of access to banking services and capital, high barriers to entry into legal cannabis markets, and exorbitant tax rates at all levels of government are clearly hampering the ability of licensed cannabis businesses to compete with the unregulated market.
Ruis directed Turner, who had no criminal record, to open bank accounts and register businesses in her name to avoid detection by law enforcement or by financial institutions. Attorney for the Eastern District of Virginia; Jarod Forget, Special Agent in Charge for the Drug Enforcement Administration’s (DEA) Washington Division; Daniel A.
Weisheit doubts that marijuana will be legalized at the federal level any time soon due to the Drug Enforcement Agency’s (DEA) position on the matter. . The DEA doesn’t even recognize medical marijuana,” Weisheit said. Due to marijuana’s status as a federal crime, banks cannot be involved with the business.
The latest piece of cannabis banking (cannabanking?) news is that protections for banks serving the legal marijuana industry have made their way into a Congressional spending bill. There was no shortage of speakers, from all walks of life, and those in favor of regulating the industry stressed the need for quick action.
Food and Drug Administration (FDA) guidance on clinical trials, Drug Enforcement Agency (DEA) licensing, material transfer agreements and cooperative research and development agreements (CRDA).
1595 – The Secure And Fair Enforcement Banking Act, which passed in the House , would prohibit federal banking regulators from penalizing banks that finance legitimate marijuana-related businesses, while its counterpart in the Senate, S. 1200 , The SAFE Banking Act, awaits a vote. 4390 and S.
Miller identifies the Rule’s highlights: It signals to banks and credit card companies that the hemp and CBD industry are legal and open for business. Its repeated shoutouts to the DEA raises concern of inappropriate enforcement actions.
Fahie and the mother and son Maynard duo are accused of agreeing to facilitate the safe passage through BVI ports of tons of Colombian cocaine headed to Miami, in exchange for millions which would be funneled through different businesses and bank accounts to hide the money’s source.
3] Further, notwithstanding the determination of the Drug Enforcement Administration (DEA), which is required to defer to the Department of Health and Human Services’ assessment that cannabis has no acceptable medical utility, 37 states and four territories have enacted laws allowing for the medical use of cannabis products. [4]
Due to cannabis businesses being considered high risk, banks will often not loan money. Credit Card Processing and Banking. The age of cannabis dispensaries has made it difficult for dispensaries to find trustworthy banking and credit card processing. You may already have the funding or you can seek a business loan.
The STATES Act passes in Congress, the President signs it and it becomes law which means that in the states where cannabis is legal : Banking system becomes available to cannabis businesses. The second path would be the administrative action by the Drug Enforcement Agency [“DEA”] and its Diversion Control Division.
1595 – The Secure And Fair Enforcement Banking Act, which passed in the House , would prohibit federal banking regulators from penalizing banks that finance legitimate marijuana-related businesses, while its counterpart in the Senate, S. 1200 , The SAFE Banking Act, awaits a vote. 4390 and S.
All of these companies, the seeds banks, cultivators, manufacturers, grow shops, distributors, and online vendors operate in a grey market that permits them to sell their products as long as they follow some rules. As a result, GW’s latest CBD product, EPIDIOLEX ® was entered into the Spanish pharmacopeia over the summer.
Seq (1970) and Drug Enforcement Administration’s (“DEA”) clutches, 2019 hemp production and sales exploded. A wildly popular nutritional supplement and food additive, oil based hemp derived products like CBD racked up $1.1 Farm Bill’s Impact and Rise of the FDA. Beyond removing plant cannabis sativa L. Budgeted at $6.1
Starting today, US manufacturers and merchants can apply through LegitScript to certify CBD products and websites that are in compliance with USDA, FDA, FTC, and DEA regulations, as well as state-specific laws.
ABA listed various problems that these businesses face under the current regulatory framework: a lack of access to banking services, “unusually high federal taxes,” no federal protection for their trademarks and an increased number of private lawsuits. “No One area that could be quickly improved is in the sourcing of research-grade marijuana.
Nonetheless, it remains illegal on a federal level with the DEA refusing to change the classification from the strictest Schedule I status last August. Until the federal status of the plant changes, weed shops will likely continue to deal with ongoing issues, from banking restrictions to advertising issues.
With increased state and federal attention on these products, there is also an increased risk to industry participants beyond that of criminal liability, such as FDA/FTC enforcement, banking and insurance obstacles, and civil liability claims. We recently discussed some of these on our Hemp Legally Speaking podcast episodes.
Accordingly, the Drug Enforcement Administration (DEA) no longer has any claim to interfere with the interstate commerce of hemp products, so as long as the THC level is at or below 0.3%. While the DEA is now officially out of the hemp regulation business, the U.S. The FDA’s position on CBD is unsettled and unsupported by law.
As we blogged about last week, the SAFE Banking Act is trying to claw its way back from the dead during this lame duck session of Congress. Interestingly, on December 2, Punchbowl News reported that the Department of Justice (DOJ) issued a memo outlining its “issues” with the SAFE Banking Act. Section 280E.
Because back then, at the start, banking was a big issue and it was a whole cash only thing, and our finance people were like, how are we going to handle this?And And now the DEA just recently poked their head into that too, so I think there’s a lot of question marks for both cultivators and processors with respect to hemp.
Indeed, just like when these states started licensing, cannabis is still on Schedule I of the Controlled Substances Act (CSA), 280E is still a nuisance, big banks still won’t bank cannabis money , and so on. I say “apparently” because HHS’s letter to DEA is redacted to the point of uselessness.
A: OK, after your get the IRB approval letter, you need permission from the Drug Enforcement Agency (DEA)– Q: Hold on. But it’s set up so that DEA works with FDA and its parent, the Department of Health and Human Services (HHS), to schedule and control all of these substances. How do I get DEA permission?
Therefore, this is not like with the SAFE Banking Act , where we have a proposed law specific to cannabis that may or may not ever pass. For more on this topic, check out our massive hemp and CBD archive , or these specific, recent posts: More Bad News for Intoxicating Hemp (California, Missouri, New Jersey) Loper Comes for the DEA.
(See Thoughts on the Terrible Pageant of Marijuana Rescheduling ) Even if marijuana is moved into Schedule III, it will still be illegal to buy and sell interstate without a DEA license, and state markets won’t fundamentally change. marijuana operators. law provided that the investment does not involve importing marijuana into the U.S.
They would get similar access to banking, SBA loans, and federal tax treatment, for starters. In short, state-legal marijuana businesses would be treated more like other businesses, outside of the frustrating prohibition on marijuana crossing state lines.
The hemp industry has definitely had its fair share of hurdles since legalization – there is uncertainty surrounding the regulatory framework, litigation against DEA , ongoing access challenges to bank and other financial services, and of course, the ripple effects of the pandemic.
Empyreal operates in 28 states, acting as a cash courier for cannabis businesses and their banks. It specifically argues that the FBI and the DEA violated federal law prohibiting the states from spending government money to interfere with legal, medical cannabis businesses in states where medical cannabis dispensaries are legal.
They write… In this week’s edition: Plans to vote on cannabis banking legislation announced in both chambers of Congress, with predictions that House will pass the SAFE Act by the end of October. DEA increases the cannabis research quota. Idaho is the home state of Senate Banking Committee Chairman Mike Crapo.
The most aggressive CPOM state we’ve seen so far is probably New York where recent court cases have really narrowed what an MSO can do when it comes to a PC (including a prohibition on holding or having access to any bank accounts on behalf of the PC).
Legal weed businesses would be able to open bank accounts, access loans, or list on the US stock market. If passed, the bill would transfer most of the regulatory authority over cannabis from the Drug Enforcement Administration (DEA) to the Food and Drug Administration (FDA).
We organize all of the trending information in your field so you don't have to. Join 14,000+ users and stay up to date on the latest articles your peers are reading.
You know about us, now we want to get to know you!
Let's personalize your content
Let's get even more personalized
We recognize your account from another site in our network, please click 'Send Email' below to continue with verifying your account and setting a password.
Let's personalize your content